FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1966064650> ?p ?o ?g. }

• W1966064650 endingPage "163" @default.
• W1966064650 startingPage "155" @default.
• W1966064650 abstract "To quantify changes in bone marrow fat fraction and determine associations with peripheral blood cell counts.In this prospective study, 19 patients received either highly myelotoxic treatment (radiation therapy plus cisplatin, 5-fluorouracil mitomycin C [FU/MMC], or cisplatin/5-FU/cetuximab) or less myelotoxic treatment (capecitabine-radiation therapy or no concurrent chemotherapy). Patients underwent MR imaging and venipuncture at baseline, midtreatment, and posttreatment visits. We performed mixed effects modeling of the mean proton density fat fraction (PDFF[%]) by linear time, treatment, and vertebral column region (lumbar [L]4-sacral [S]2 vs thoracic [T]10-L3 vs cervical[C]3-T9), while controlling for cumulative mean dose and other confounders. Spearman rank correlations were performed by white blood cell (WBC) counts versus the differences in PDFF(%) before and after treatment.Cumulative mean dose was associated with a 0.43% per Gy (P=.004) increase in PDFF(%). In the highly myelotoxic group, we observed significant changes in PDFF(%) per visit within L4-S2 (10.1%, P<.001) and within T10-L3 (3.93%, P=.01), relative to the reference C3-T9. In the less myelotoxic group, we did not observe significant changes in PDFF(%) per visit according to region. Within L4-S2, we observed a significant difference between treatment groups in the change in PDFF(%) per visit (5.36%, P=.04). Rank correlations of the inverse log differences in WBC versus the differences in PDFF(%) overall and within T10-S2 ranged from 0.69 to 0.78 (P<.05). Rank correlations of the inverse log differences in absolute neutrophil counts versus the differences in PDFF(%) overall and within L4-S2 ranged from 0.79 to 0.81 (P<.05).Magnetic resonance imaging fat quantification is sensitive to marrow composition changes that result from chemoradiation therapy. These changes are associated with peripheral blood cell counts. This study supports a rationale for bone marrow-sparing treatment planning to reduce the risk of hematologic toxicity." @default.
• W1966064650 created "2016-06-24" @default.
• W1966064650 creator A5013471928 @default.
• W1966064650 creator A5031102427 @default.
• W1966064650 creator A5037985715 @default.
• W1966064650 creator A5039944358 @default.
• W1966064650 creator A5044870790 @default.
• W1966064650 creator A5047674032 @default.
• W1966064650 creator A5066775246 @default.
• W1966064650 creator A5073658135 @default.
• W1966064650 creator A5076009988 @default.
• W1966064650 creator A5086591204 @default.
• W1966064650 date "2014-09-01" @default.
• W1966064650 modified "2023-10-12" @default.
• W1966064650 title "Fat Composition Changes in Bone Marrow During Chemotherapy and Radiation Therapy" @default.
• W1966064650 cites W1546909751 @default.
• W1966064650 cites W1831183617 @default.
• W1966064650 cites W1896068987 @default.
• W1966064650 cites W1964283912 @default.
• W1966064650 cites W1965877617 @default.
• W1966064650 cites W1976346294 @default.
• W1966064650 cites W1977336247 @default.
• W1966064650 cites W1988707139 @default.
• W1966064650 cites W1993849755 @default.
• W1966064650 cites W2000335266 @default.
• W1966064650 cites W2002225209 @default.
• W1966064650 cites W2025584396 @default.
• W1966064650 cites W2047348005 @default.
• W1966064650 cites W2048796784 @default.
• W1966064650 cites W2058580369 @default.
• W1966064650 cites W2066077329 @default.
• W1966064650 cites W2069846825 @default.
• W1966064650 cites W2076910504 @default.
• W1966064650 cites W2082246284 @default.
• W1966064650 cites W2083192741 @default.
• W1966064650 cites W2092767351 @default.
• W1966064650 cites W2112079038 @default.
• W1966064650 cites W2124995644 @default.
• W1966064650 cites W2137281603 @default.
• W1966064650 cites W2139410896 @default.
• W1966064650 cites W2146566287 @default.
• W1966064650 cites W2154312373 @default.
• W1966064650 cites W2155802635 @default.
• W1966064650 cites W2161971256 @default.
• W1966064650 cites W2164891366 @default.
• W1966064650 cites W3103979403 @default.
• W1966064650 doi "https://doi.org/10.1016/j.ijrobp.2014.05.041" @default.
• W1966064650 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4159416" @default.
• W1966064650 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25015207" @default.
• W1966064650 hasPublicationYear "2014" @default.
• W1966064650 type Work @default.
• W1966064650 sameAs 1966064650 @default.
• W1966064650 citedByCount "62" @default.
• W1966064650 countsByYear W19660646502014 @default.
• W1966064650 countsByYear W19660646502015 @default.
• W1966064650 countsByYear W19660646502016 @default.
• W1966064650 countsByYear W19660646502017 @default.
• W1966064650 countsByYear W19660646502018 @default.
• W1966064650 countsByYear W19660646502019 @default.
• W1966064650 countsByYear W19660646502020 @default.
• W1966064650 countsByYear W19660646502021 @default.
• W1966064650 countsByYear W19660646502022 @default.
• W1966064650 countsByYear W19660646502023 @default.
• W1966064650 crossrefType "journal-article" @default.
• W1966064650 hasAuthorship W1966064650A5013471928 @default.
• W1966064650 hasAuthorship W1966064650A5031102427 @default.
• W1966064650 hasAuthorship W1966064650A5037985715 @default.
• W1966064650 hasAuthorship W1966064650A5039944358 @default.
• W1966064650 hasAuthorship W1966064650A5044870790 @default.
• W1966064650 hasAuthorship W1966064650A5047674032 @default.
• W1966064650 hasAuthorship W1966064650A5066775246 @default.
• W1966064650 hasAuthorship W1966064650A5073658135 @default.
• W1966064650 hasAuthorship W1966064650A5076009988 @default.
• W1966064650 hasAuthorship W1966064650A5086591204 @default.
• W1966064650 hasBestOaLocation W19660646502 @default.
• W1966064650 hasConcept C126322002 @default.
• W1966064650 hasConcept C126894567 @default.
• W1966064650 hasConcept C143998085 @default.
• W1966064650 hasConcept C151032500 @default.
• W1966064650 hasConcept C2776694085 @default.
• W1966064650 hasConcept C2778488018 @default.
• W1966064650 hasConcept C2780007613 @default.
• W1966064650 hasConcept C2989005 @default.
• W1966064650 hasConcept C509974204 @default.
• W1966064650 hasConcept C71924100 @default.
• W1966064650 hasConcept C90924648 @default.
• W1966064650 hasConceptScore W1966064650C126322002 @default.
• W1966064650 hasConceptScore W1966064650C126894567 @default.
• W1966064650 hasConceptScore W1966064650C143998085 @default.
• W1966064650 hasConceptScore W1966064650C151032500 @default.
• W1966064650 hasConceptScore W1966064650C2776694085 @default.
• W1966064650 hasConceptScore W1966064650C2778488018 @default.
• W1966064650 hasConceptScore W1966064650C2780007613 @default.
• W1966064650 hasConceptScore W1966064650C2989005 @default.
• W1966064650 hasConceptScore W1966064650C509974204 @default.
• W1966064650 hasConceptScore W1966064650C71924100 @default.
• W1966064650 hasConceptScore W1966064650C90924648 @default.
• W1966064650 hasIssue "1" @default.

• next